Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arrivent Biopharma, Inc. (AVBP) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arrivent Biopharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1868279.
Total stock buying since 2024: $33,999,966.
Total stock sales since 2024: $0.
Total stock option exercises since 2024: $117,663.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 11,153 | $25,428 |
| 2024 | 1,888,887 | $33,999,966 | 0 | $0 | 27,566 | $92,235 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 0 | $0 | 11,153 | $25,428 |
| 2024-09 | 0 | $0 | 0 | $0 | 27,566 | $92,235 |
| 2024-01 | 1,888,887 | $33,999,966 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-11 | Lachapelle Robin (Chief Operating Officer) | Option Ex | 11,153 | 2.28 | 25,428 |
| 2024-09-19 | Lachapelle Robin (Chief Operating Officer) | Option Ex | 27,566 | 3.35 | 92,235 |
| 2024-01-30 | Orbimed Asia Gp Iv, L.p. | Buy | 444,444 | 18.00 | 7,999,992 |
| 2024-01-30 | Hhlr Advisors, Ltd. | Buy | 555,555 | 18.00 | 9,999,990 |
| 2024-01-30 | Gordon Carl L | Buy | 444,444 | 18.00 | 7,999,992 |
| 2024-01-30 | Healy James | Buy | 444,444 | 18.00 | 7,999,992 |
Insider trading activities including stock purchases, stock sales, and option exercises of AVBP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arrivent Biopharma, Inc. (symbol AVBP, CIK number 1868279) see the Securities and Exchange Commission (SEC) website.